Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma

Science

Volumn 343, Issue 6167, 2014, Pages 189-193

  Johnson, Brett E ^a   Mazor, Tali ^a   Hong, Chibo ^a   Barnes, Michael ^a   Aihara, Koki ^b,c   McLean, Cory Y ^a,g   Fouse, Shaun D ^a   Yamamoto, Shogo ^b   Ueda, Hiroki ^b   Tatsuno, Kenji ^b   Asthana, Saurabh ^a,d   Jalbert, Llewellyn E ^a   Nelson, Sarah J ^a   Bollen, Andrew W ^a   Gustafson, W Clay ^a   Charron, Elise ^a   Weiss, William A ^a   Smirnov, Ivan V ^a   Song, Jun S ^a,e   Olshen, Adam B ^a,d   Cha, Soonmee ^a   Zhao, Yongjun ^f   Moore, Richard A ^f   Mungall, Andrew J ^f   Jones, Steven J M ^f   Hirst, Martin ^f   Marra, Marco A ^f   Saito, Nobuhito ^c   Aburatani, Hiroyuki ^b   Mukasa, Akitake ^c   Berger, Mitchel S ^a   Chang, Susan M ^a   Taylor, Barry S ^a,d   Costello, Joseph F ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g Department of Bioengineering and Therapeutic Sciences University of California ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BRG1 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; PROTEIN P53; TEMOZOLOMIDE;

CANCER; GENOMICS; MAMMAL; MORTALITY; MUTATION; TUMOR;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLONAL EVOLUTION; CONTROLLED STUDY; EXOME; GENE MUTATION; GENE SEQUENCE; GLIOMA; HUMAN; MULTIMODALITY CANCER THERAPY; MUTAGENESIS; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETINOBLASTOMA;

MAMMALIA;

EID: 84892373020     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1239947     Document Type: Article

References (36)

1. M. Gerlinger, C. Swanton, Br. J. Cancer 103, 1139-1143 (2010).
2. M. Greaves, C. C. Maley, Nature 481, 306-313 (2012).
3. D. A. Landau et al., Cell 152, 714-726 (2013).
4. L. Ding et al., Nature 481, 506-510 (2012).
5. M. Gerlinger et al., N. Engl. J. Med. 366, 883-892 (2012).
6. S. Yachida et al., Nature 467, 1114-1117 (2010).
7. X. Wu et al., Nature 482, 529-533 (2012).
8. N. Sanai, S. Chang, M. S. Berger, J. Neurosurg. 115, 948-965 (2011).
9. M. Westphal, K. Lamszus, Nat. Rev. Neurosci. 12, 495-508 (2011).
10. Y. Jiao et al., Oncotarget 3, 709-722 (2012).
11. T. Watanabe, S. Nobusawa, P. Kleihues, H. Ohgaki, Am. J. Pathol. 174, 1149-1153 (2009).
12. K. Watanabe et al., Clin. Cancer Res. 3, 523-530 (1997).
13. P. P. Medina et al., Hum. Mutat. 29, 617-622 (2008).
14. S. Glaros, G. M. Cirrincione, A. Palanca, D. Metzger, D. Reisman, Cancer Res. 68, 3689-3696 (2008).
15. D. Rohle et al., Science 340, 626-630 (2013).
16. N. J. Szerlip et al., Proc. Natl. Acad. Sci. U.S.A. 109, 3041-3046 (2012).
17. A. Sottoriva et al., Proc. Natl. Acad. Sci. U.S.A. 110, 4009-4014 (2013).
18. L. M. F. Merlo, J. W. Pepper, B. J. Reid, C. C. Maley, Nat. Rev. Cancer 6, 924-935 (2006).
19. W. J. Bodell, N. W. Gaikwad, D. Miller, M. S. Berger, Cancer Epidemiol. Biomarkers Prev. 12, 545-551 (2003).
20. C. Greenman et al., Nature 446, 153-158 (2007).
21. Cancer Genome Atlas Research Network, Nature 455, 1061-1068 (2008).
22. C. Hunter et al., Cancer Res. 66, 3987-3991 (2006).
23. D. P. Cahill et al., Clin. Cancer Res. 13, 2038-2045 (2007).
24. S. Yip et al., Clin. Cancer Res. 15, 4622-4629 (2009).
25. G. Reifenberger, J. Reifenberger, K. Ichimura, P. S. Meltzer, V. P. Collins, Cancer Res. 54, 4299-4303 (1994).
26. H. Wang et al., Lab. Invest. 84, 941-951 (2004).
27. D. N. Louis, Annu. Rev. Pathol. 1, 97-117 (2006).
28. T. Tsai et al., Arch. Ophthalmol. 122, 239-248 (2004).
29. C. Houdayer et al., Hum. Mutat. 23, 193-202 (2004).
30. X. Q. Qin, T. Chittenden, D. M. Livingston, W. G. Kaelin Jr., Genes Dev. 6, 953-964 (1992).
31. J. Koh, G. H. Enders, B. D. Dynlacht, E. Harlow, Nature 375, 506-510 (1995).
32. S. A. Forbes et al., Curr. Protoc. Hum. Genet. Chapter 10, Unit 10.11 (2008).
33. M. C. Fargnoli et al., J. Invest. Dermatol. 111, 1202-1206 (1998).
34. S. Kang, A. G. Bader, P. K. Vogt, Sci. U.S.A. 102, 802-807 (2005).
35. S. Y. Han et al., Cancer Res. 60, 3147-3151 (2000).
36. T. Sato, A. Nakashima, L. Guo, K. Coffman, F. Tamanoi, Oncogene 29, 2746-2752 (2010).